Keywords: tarceva, approved, canada, lung, cancer, osi, pharmaceuticals

Tarceva approved in Canada for lung cancer

Article | 25 July 2005

Print This

OSI Pharmaceuticals of the USA says that Health Canada has cleared the use of Tarceva (erlotinib) for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in